# LENZ Therapeutics (LENZ) — Earnings

LENZ · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/lenz/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | −$1.02 |
| EPS estimate | −$1.05 |
| EPS surprise | +2.90% |
| Revenue surprise | +130.76% |
| Revenue | $5.5M |
| Revenue estimate | $2.4M |
| Reported | Aug 11, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1815776/000181577626000052/lenz-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/ce9d816b-5929-d5e8-331a-3c7f5f1c64b8.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 11, 2026 | −$1.05 | −$1.02 | 2.90% | $2.4M | $5.5M |
| Q1 2026 | May 11, 2026 | −$1.05 | −$1.32 | -25.99% | $1.8M | $1.9M |
| Q4 2025 | Mar 24, 2026 | −$0.91 | −$1.16 | -27.71% | $3.1M | $1.6M |
| Q3 2025 | Nov 5, 2025 | −$0.69 | −$0.59 | 14.78% | $4.6M | $12.5M |
| Q2 2025 | Jul 30, 2025 | −$0.61 | −$0.53 | 13.14% | $714,286.00 | $5.0M |
| Q1 2025 | May 7, 2025 | −$0.52 | −$0.53 | -2.26% | — | — |
| Q4 2024 | Mar 19, 2025 | −$0.41 | −$0.46 | -12.20% | — | — |
| Q3 2024 | Nov 6, 2024 | −$0.46 | −$0.38 | 17.07% | — | — |
| Q2 2024 | Aug 14, 2024 | −$0.48 | −$0.40 | 16.44% | — | — |
| Q1 2024 | May 8, 2024 | −$0.82 | −$3.53 | -330.49% | — | — |
| Q4 2023 | Feb 27, 2024 | −$0.91 | −$2.58 | -182.97% | — | — |
| Q2 2023 | Aug 14, 2023 | −$6.79 | −$6.79 | 0.00% | — | — |
| Q1 2023 | May 11, 2023 | −$2.41 | −$3.01 | -25.00% | — | — |
| Q4 2022 | Mar 20, 2023 | −$3.45 | −$3.08 | 10.83% | — | — |
| Q3 2022 | Nov 9, 2022 | −$3.11 | −$3.15 | -1.29% | — | — |
| Q2 2022 | Aug 11, 2022 | −$3.44 | −$3.36 | 2.31% | — | — |
| Q1 2022 | May 12, 2022 | −$2.73 | −$3.36 | -23.08% | — | — |
| Q4 2021 | Mar 21, 2022 | −$2.08 | −$2.45 | -17.65% | — | — |
| Q3 2021 | Nov 10, 2021 | −$1.94 | −$1.96 | -1.20% | — | — |
| Q2 2021 | Aug 12, 2021 | −$2.03 | −$24.15 | -1089.66% | — | — |

## Frequently Asked Questions

### When did LENZ Therapeutics (LENZ) last report earnings?

LENZ Therapeutics last reported on Aug 11, 2026, covering fiscal Q2 2026.

### Did LENZ beat earnings estimates?

Yes. LENZ Therapeutics reported EPS of −$1.02 for Q2 2026 against a −$1.05 estimate — a 2.90% beat.

### How much revenue did LENZ report last quarter?

LENZ Therapeutics reported $5.5M in revenue for Q2 2026, against a consensus estimate of $2.4M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).